Verona pharma to present at 43rd annual canaccord growth conference

London and raleigh, n.c., july 26, 2023 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma” or the “company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that senior management will present a company overview at the 43rd annual canaccord growth conference on wednesday, august 9, 2023 at 12:00 pm edt / 5:00 pm bst.

VRNA Ratings Summary

VRNA Quant Ranking